First Time Loading...

ImmuCell Corp
NASDAQ:ICCC

Watchlist Manager
ImmuCell Corp Logo
ImmuCell Corp
NASDAQ:ICCC
Watchlist
Price: 5.14 USD 0.78%
Updated: Apr 29, 2024
Section:
 

Wall Street
Price Targets

ICCC Price Targets Summary
ImmuCell Corp

Wall Street analysts forecast ICCC stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ICCC is 14 USD .

ICCC Lowest Forecast
Wall Street Target
Not Available
ICCC Average Forecast
Wall Street Target
14 USD
172% Upside
ICCC Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
14 USD
172% Upside
Highest
Price Target
Not Available
ImmuCell Corp Competitors:
Price Targets
PANACEABIO
Panacea Biotec Ltd
52% Downside
SPRO
Spero Therapeutics Inc
420% Upside
Y
YS
YS Biopharma Co Ltd
451% Upside
KNTE
Kinnate Biopharma Inc
9% Downside
PANACEABIO
Panacea Biotec Ltd
52% Downside
SPRO
Spero Therapeutics Inc
420% Upside
Y
YS
YS Biopharma Co Ltd
451% Upside
KNTE
Kinnate Biopharma Inc
9% Downside
ASND
Ascendis Pharma A/S
35% Upside
2INV
2Invest AG
72% Downside
688687
Beijing Kawin Technology Share-holding Co Ltd
44% Upside
688363
Bloomage Biotechnology Corp Ltd
60% Upside

Revenue
Forecast

Revenue Estimate
ImmuCell Corp

For the last 8 years the compound annual growth rate for ImmuCell Corp's revenue is 7%. The projected CAGR for the next 3 years is -4%.

7%
Past Growth
-4%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
ImmuCell Corp

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
ImmuCell Corp

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

See Also

Summary
ICCC intrinsic value, competitors valuation, and company profile.
DCF Valuation
ICCC stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ICCC stock valuation using valuation multiples.
Wall Street Estimates
ICCC price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ICCC stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ICCC's stock price target?
Price Target
14 USD

According to Wall Street analysts, the average 1-year price target for ICCC is 14 USD .

What is ImmuCell Corp's Revenue forecast?
Projected CAGR
-4%

For the last 8 years the compound annual growth rate for ImmuCell Corp's revenue is 7%. The projected CAGR for the next 3 years is -4%.

ALPHA SPREAD
Join more than 132,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.